Pure single-incision robotic surgery using the da Vinci SP system demonstrated comparable short-term safety and oncological adequacy to the Xi system, with modest advantages in incision length and postoperative pain. No clear benefit in systemic inflammatory response was observed, and further validation in larger, prospective, multicenter studies is warranted.
Akuta et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: